// App-Quantinova.ai

S1059 2016 AHA : Change in Serum PCSK9 Does Not Explain the Difference in the LDL-C Response Between EPA and DHA Supplementation: The ComparED Study

Researchers

Presenter

  • Patrick Couture

Principal Investigators

  • Amelie Charest

  • Johanne Marin

  • Marie-Claude Lepine

  • Andre Tchernof

  • Benoit Lamarche

Medical Centers

  • Laval University, Quebec, Quebec, Canada.

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Systemic inflammation

  • Obesity

Biomarkers

  • Proprotein convertase subtilisin/kexin type 9

  • TIMP Metallopeptidase Inhibitor 1

Drug/Treatment

  • Icosapent ethyl

  • Docosahexaenoic acid

Outcome

  • N/A

Study Design

  • randomized

  • cross over

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved